Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Healthtrust
McKesson
Baxter
Colorcon
Chinese Patent Office

Generated: September 18, 2019

DrugPatentWatch Database Preview

Patent: 7,956,167

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 7,956,167
Title:Purification of collagenases from clostridium histolyticum liquid culture
Abstract: The present invention provides a method for purifying Clostridium histolyticum collagenase type I and type II proteins from a complex mixture by subsequently performing a precipitation with ammonium sulfate, hydrophobic interaction chromatography, cation exchange chromatography, and anion chromatography. Conditions are provided which lead to a stabilized, partially purified preparation even after the precipitation step. The method of the invention leads to a quick and efficient removal of other proteolytic activities. The preparations according to the invention provide exceptionally pure and intact collagenase type I and type II proteins which are enzymatically active. The invention also provides blends of the two isolated proteins. The invention further provides the use of the purified collagenase proteins or blends thereof for treating a tissue sample in vitro.
Inventor(s): Hoelke; Werner (Penzberg, DE), Eckstein; Hellmut (Weilheim, DE), Fischer; Michaela (Wolfratshausen, DE), Liehre; Antje (Penzberg, DE), Suppmann; Bernhard (Weilheim, DE), Thalhofer; Johann-Peter (Weilheim, DE)
Assignee: Roche Diagnostics Operations, Inc. (Indianapolis, IN)
Application Number:12/474,488
Patent Claims:see list of patent claims

Details for Patent 7,956,167

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Advance Biofactures SANTYL collagenase VIAL 101995 001 1965-06-04   Try a Free Trial Roche Diagnostics Operations, Inc. (Indianapolis, IN) 2028-06-02 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
QuintilesIMS
Medtronic
Fish and Richardson
Farmers Insurance
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.